Q1 2026 Conmed Corp Earnings Call Transcript
Key Points
- Conmed Corp (CNMD) successfully divested its gastroenterology product lines, allowing the company to focus on higher growth and higher margin offerings.
- The AirSeal platform continues to show strong growth potential, with a large installed base and increasing adoption in laparoscopic procedures.
- Buffalo Filter's smoke evacuation platform is benefiting from legislative support, with 20 US states enacting smoke-free operating room laws.
- BioBrace is gaining recognition as a differentiated solution in soft tissue repair, with increasing surgeon adoption and clinical validations.
- Conmed Corp (CNMD) reported improved supply chain performance, enabling consistent service and supporting sustained growth in orthopedics.
- Total sales for the first quarter decreased by 1.3% compared to the prior-year quarter, impacted by the exit from the gastroenterology product lines.
- Adjusted net income decreased by 8.5% year-over-year, and adjusted diluted net earnings per share decreased by 6.3% year-over-year.
- General surgery sales declined by 7.4% in constant currency, with OEM smoke products being a significant headwind.
- The company faces inflationary pressures on commodity products, affecting the cost of goods sold.
- Interest expenses are expected to increase due to refinancing with bank debt, potentially impacting adjusted EPS by at least $0.10.
Good day and thank you for standing by. Welcome to CONMED's first quarter fiscal 2026 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
Before the conference call begins, let me remind you that during this call, management will be making comments and statements regarding its financial outlook, its plans and objectives. These statements represent the forward-looking statements that involve risk and uncertainties, as those terms are defined under the Federal Securities laws.
Investors are cautioned that any such forward-looking statements are not guarantees of future events, performance, or results. The company's actual results may differ materially from its current expectations. Please refer to the risk and other uncertainties disclosed under theing forward-lookinging information and today's press release, as well as the company's SEC filings for more details on the risk and uncertainties that may cause actual results to differ materially.
The company disclaims any obligation to update any forward-looking statements
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
